OR WAIT null SECS
Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.
March 02, 2019
A monoplant may offer greater supply security and flexibility for specialist medicines.
Bio/pharma companies facing new challenges in light of the increasing HPAPI market may benefit from outsourcing.
As biologics continue to push boundaries, the industry needs to take a holistic approach to formulation to ensure success.
As drug pricing comes under the microscope internationally, it appears that collaboration with all stakeholders is key to tackling the issue.
Harmonization of best practices and regulatory requirements will enable developers to find the best stability testing approach.
February 06, 2019
Drug solubility can benefit from approaching solubility issues early on in the drug lifecycle.